Breweries from around the world are invited to join Ales for ALS. Once accepted, participating Ales for ALS brewers receive their requested amount of the unique hop blend, created and donated annually by Loftus Ranches and YCH Hops exclusively for brewers participating in this fundraising program. There is no charge to brewers for this amazing hop blend. Ales for ALS brewers donate $1 to the ALS Therapy Development Institute for each pint of the resulting Ales for ALS brew sold. The funds raised are spent immediately on their mission to discover and develop effective treatments for ALS.

Initial invitations have already been sent out for the 2018 Ales for ALS season. Participation is limited by the hop supply. If you would like to inquire about receiving an invitation, click here.

LEARN MORE

LEARN MORE

Each year, breweries from around the world are invited to join Ales for ALS. They receive a unique blend of hops, created annually by Loftus Ranches and YCH Hops, FREE OF CHARGE. Breweries donate $1 from every pint sold to the ALS Therapy Development Institute.

Breweries receive an invitation for the 2018 season in January, after the 2017 season has closed. Participation is limited by the hop blend supply.

#ALESFORALS

loader

Loading Gallery...

ABOUT THE ALS THERAPY DEVELOPMENT INSTITUTE

The ALS Therapy Development Institute and our scientists actively discover and develop treatments for ALS. We are the world's first and largest nonprofit biotech focused 100 percent on ALS research. Led by people with ALS and drug development experts, we understand the urgent need to slow and stop this disease. Learn more at www.als.net.

ABOUT ALS

Every 90 minutes, someone is diagnosed with ALS, also known as Lou Gehrig's disease or Motor Neuron Disease (MND). It is a progressive, neurodegenerative disease that causes muscle weakness, difficulty breathing and swallowing, and paralysis while leaving the senses intact. ALS attacks certain cells in the brain and spinal cord needed to keep muscles moving. Most people survive two to five years after their diagnosis, with an estimated 30,000 people in the US and 450,000 worldwide living with the disease. Currently, there is no effective treatment or cure.

ABOUT THE ALS THERAPY DEVELOPMENT INSTITUTE

The ALS Therapy Development Institute and our scientists actively discover and develop treatments for ALS. We are the world's first and largest nonprofit biotech focused 100 percent on ALS research. Led by people with ALS and drug development experts, we understand the urgent need to slow and stop this disease. Learn more at www.als.net.

ABOUT ALS

Every 90 minutes, someone is diagnosed with ALS, also known as Lou Gehrig's disease or Motor Neuron Disease (MND). It is a progressive, neurodegenerative disease that causes muscle weakness, difficulty breathing and swallowing, and paralysis while leaving the senses intact. ALS attacks certain cells in the brain and spinal cord needed to keep muscles moving. Most people survive two to five years after their diagnosis, with an estimated 30,000 people in the US and 450,000 worldwide living with the disease. Currently, there is no effective treatment or cure.